San Francisco-based venture capital firm Burrill & Company is partnering up with Chile's Austral Capital Partners to put together an initial $40 million to $50 million life sciences venture capital fund in Chile.
"We expect to initially have between $40 million and $50 million committed over the next few months...although the idea would be to have between $100 million and $150 million over the next several years," Steven Burrill, the chief executive of the U.S. company, told Dow Jones Newswires.
To read the full, original article click on this link: Burrill To Create Chile Life Sciences Venture Capital Fund-CEO - WSJ.com
Author: Anthony Esposito